What Is the Difference Between Biohazardous Waste and Regulated Medical Waste?

Regulated medical waste (RMW) and biohazardous waste are both terms used to refer to medical waste which has the potential to transmit infectious diseases to humans. Many states define “medical waste” as any type of healthcare-related waste generated from treatment of humans or animals, even if its disposal isn’t regulated. They use the terms “biohazardous waste” or “regulated medical waste” to refer to medical waste that is subject to specific disposal rules and regulations.
Continue reading “What Is the Difference Between Biohazardous Waste and Regulated Medical Waste?”


MedSafe Milestone: One Million Pounds – And Counting

Since 2014, Sharps Compliance has partnered with pharmacies, hospitals and clinics with on-site pharmacies, law enforcement agencies, and others to make approximately 3,000 MedSafe pharmaceutical collection kiosks accessible to ultimate users for the disposal of their home medicines. Those with unused/unwanted medications can – at no cost – bring their home medicines to a MedSafe unit for safe, DEA-complaint disposal. The program has generated an enthusiastic response: as of December 2018, over a million pounds of unused, ultimate-user medications have been deposited into MedSafe receptacles.
Continue reading “MedSafe Milestone: One Million Pounds – And Counting”


North Dakota Pharmacists Use MedSafe to Help Fight Opioid Abuse

North Dakota’s innovative approach to combating the opioid crisis in rural America involves stakeholders at every level – from pharmaceutical companies to the public. Although the state’s death rate from opioid overdoses is less than half the national average, officials were alarmed when it spiked in 2016. In response, the state launched several new initiatives that focused on education, front-line prevention, and drug collection/diversion using Sharps Compliance MedSafe Medication Disposal System kiosks.
Continue reading “North Dakota Pharmacists Use MedSafe to Help Fight Opioid Abuse”


New Laws and Prescription Guidelines Target Opioid Abuse Crisis

In 2017, the Food and Drug Administration (FDA) expressed concern that physicians were contributing to the opioid epidemic by over-prescribing the drugs. Recent evidence shows that doctors paid attention. In July, Blue Cross Blue Shield reported 2017 numbers showing fewer opioid prescriptions and an increase in new prescriptions meeting the Centers for Disease Control and Prevention’s chronic pain prescription guidelines.
Continue reading “New Laws and Prescription Guidelines Target Opioid Abuse Crisis”


Prepare for OSHA Inspections with ComplianceTrac

Workplace safety is a serious issue that affects your bottom line. The Occupational Safety and Health Administration (OSHA) estimates that direct workers’ compensation claims cost US employers $1 billion each week. Unfortunately, in many companies, safety training and education begins and ends with a dusty bookshelf full of “safety manuals” and brightly colored “Safety First!” posters in the break room.
Continue reading “Prepare for OSHA Inspections with ComplianceTrac”